Shanghai Feiwei Information Technology has raised 100 million yuan ($15 million) in a Series B round of financing co-led by Redpoint China Ventures and GP Capital, while Zeesan Biotech has garnered $10 million from Sinovation Ventures.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
